Intended for healthcare professionals

Naevi and melanoma

There are 8,000 new cases a year of malignant melanoma in the UK, with 1,800 deaths, making it the most serious skin cancer despite being one of the least common. Recognition and early referral to dermatologists is paramount in achieving the best prognosis. However, it is not always easy to differentiate benign lesions from malignant ones. Of all the benign lesions confused for malignant melanoma, melanocytic naevi (MN) feature prominently. Greater awareness of the classical features of both naevi and melanoma will minimise misdiagnoses.
Dermatology in practice 2007; 15(1): 21–24
To continue reading this article, please sign in or register.